We are live on
!
Find out more
MBE
Michael B. Elefante Portfolio holdings
AUM
$91.5M
1-Year Est. Return
13.24%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$185M
Cap. Flow
% of AUM
100.56%
Top 10 Holdings %
Top 10 Hldgs %
35.73%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$7.69M |
| 2 |
CVS Health
CVS
|
+$7.64M |
| 3 |
Emerson Electric
EMR
|
+$6.95M |
| 4 |
Novartis
NVS
|
+$6.93M |
| 5 |
Procter & Gamble
PG
|
+$6.82M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.97% |
| 2 | Technology | 20.49% |
| 3 | Industrials | 17.98% |
| 4 | Energy | 10.31% |
| 5 | Consumer Staples | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$646B
| $7.78M | 4.22% |
+90,570
| New | +$7.69M |
|
|
2
CVS Health
CVS
$119B
| $7.54M | 4.09% |
+131,916
| New | +$7.64M |
|
|
3
Novartis
NVS
$292B
| $6.75M | 3.66% |
+106,489
| New | +$6.93M |
|
|
4
Emerson Electric
EMR
$86.6B
| $6.74M | 3.66% |
+123,635
| New | +$6.95M |
|
5
Canadian National Railway
CNI
$76.2B
| $6.7M | 3.64% |
+137,840
| New | +$6.8M |
|
|
6
Procter & Gamble
PG
$334B
| $6.69M | 3.63% |
+86,865
| New | +$6.82M |
|
7
Mastercard
MA
$521B
| $6M | 3.26% |
+104,500
| New | +$5.81M |
|
8
PepsiCo
PEP
$193B
| $5.96M | 3.24% |
+72,930
| New | +$5.96M |
|
9
3M
MMM
$89.9B
| $5.54M | 3% |
+60,542
| New | +$5.5M |
|
|
COV
10
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $5.16M | 2.8% |
+92,552
| New | +$5.35M |
|
11
Automatic Data Processing
ADP
$114B
| $5.04M | 2.73% |
+83,278
| New | +$4.97M |
|
12
AptarGroup
ATR
$8.46B
| $5.03M | 2.73% |
+91,110
| New | +$5.12M |
|
|
EMC
13
DELISTED
EMC CORPORATION
EMC
| $4.77M | 2.59% |
+201,925
| New | +$4.76M |
|
14
ExxonMobil
XOM
$644B
| $4.56M | 2.48% |
+50,515
| New | +$4.55M |
|
15
Oracle
ORCL
$435B
| $4.34M | 2.36% |
+141,255
| New | +$4.69M |
|
16
Chevron
CVX
$396B
| $4.28M | 2.32% |
+36,141
| New | +$4.37M |
|
17
Intel
INTC
$473B
| $4.27M | 2.32% |
+176,236
| New | +$4.16M |
|
18
Perrigo
PRGO
$2.01B
| $3.83M | 2.08% |
+31,673
| New | +$3.75M |
|
19
Apple
AAPL
$4.67T
| $3.63M | 1.97% |
+255,948
| New | +$3.94M |
|
20
SLB Ltd
SLB
$85.1B
| $3.38M | 1.83% |
+47,155
| New | +$3.49M |
|
21
Pembina Pipeline
PBA
$27.9B
| $3.08M | 1.67% |
+100,600
| New | +$3.21M |
|
22
Deere & Co
DE
$170B
| $3.01M | 1.64% |
+37,070
| New | +$3.2M |
|
23
Teva Pharmaceuticals
TEVA
$42.5B
| $2.65M | 1.44% |
+67,545
| New | +$2.63M |
|
24
RTX Corp
RTX
$285B
| $2.61M | 1.42% |
+44,643
| New | +$2.64M |
|
25
Microsoft
MSFT
$3.81T
| $2.49M | 1.35% |
+72,091
| New | +$2.36M |
|
Similar funds
AEPI
CC
TM
VNB
ECP
WIL
RCM
ZTNA
Michael B. Elefante's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Michael B. Elefante, which disclosed 108 positions worth $184M. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Johnson & Johnson: 90,570 shares worth $7.78M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, followed by Technology and Industrials.
- Michael B. Elefante's largest Q2 2013 buy was Johnson & Johnson: 90,570 shares worth $7.78M.
- Michael B. Elefante's ten largest holdings make up 36% of its $184M portfolio in Q2 2013.
- Michael B. Elefante disclosed 108 positions in Q2 2013, its first 13F filing on record.
Based on Michael B. Elefante's 13F filing for Q2 2013, filed 19 Aug 2013.